In This Section      

Ciccarone Articles

Ciccarone Center Research


Emotional Health

Significant depressive symptoms are not associated with diabetes control in minority elderly.
By: Palta P, Golden SH, Teresi JA, Palmas W, Trief P, Weinstock RS, Shea A, Manly JJ, Luchsinger JA.
Elevated depressive symptoms were not associated with metabolic control of diabetes among minority elderly individuals.
Read on Pubmed
Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: The Multi-Ethnic Study of Atherosclerosis.
By: Remigio-Baker RA, Allison MA, Schreiner P, Szklo M, Crum RM, Leoutsakos J, Franco M, Carnethon MR, Nettleton J, Mujahid M, Diez Roux AV, Jensky N, Golden SH.
Sex, but not race/ethnicity, was found to modify the relationship between elevated depressive symptoms and visceral fat mass. Among men, a significant positive association was found between depressive symptoms and visceral adiposity, but no significant relationship was found among women.
Read on Pubmed
NIDDK international conference report on diabetes and depression: Current understanding and future directions.
By: Holt RIG, deGroot M, Lucki I, Hunter CM, Sartorius N, Golden SH.
Comorbid diabetes and depression are a major clinical challenge as the outcomes of each condition are worsened by the other. This article summarizes the presentations and discussions during an international meeting on diabetes and depression convened by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in collaboration with the National Institute of Mental Health and the Dialogue on Diabetes and Depression.
Read on Pubmed
Diabetes and depression.
By: Holt RI, de Groot M, Golden SH.
Both psychological interventions and antidepressants are effective in treating depressive symptoms in people with diabetes but have mixed effects on glycemic control.
Read on Pubmed
Type 2 diabetes and cardiovascular disease: what next?
By: Joseph JJ, Golden SH.

CVD in Type 2 diabetes is multifactorial and requires a multifaceted approach in reducing known cardiovascular risks, at both the individual patient and societal levels.

Read on Pubmed
Physical environment may modify the association between depressive symptoms and change in waist circumference: the multi-ethnic study of atherosclerosis.
By: Remigio-Baker RA, Diez Roux AV, Szklo M, Crum RM, Leoutsakos JM, Franco M, Schreiner PJ, Carnethon MR, Nettleton JA, Mujahid MS, Michos ED, Gary-Webb TL, Golden SH.

Elevated depressive symptoms were associated with greater increase in waist circumference among individuals living in poorly rated physical environments than in those in better-rated physical environments.

Read on Pubmed
Association of depressive symptoms and anti-depressants with body mass index and waist circumference in elderly men and women: The ARIC Carotid MRI Study.
By: Golden SH, Hsu H, Astor BC, Malhotra S, Wand GS, Wasserman BA.

Depressive symptoms are associated with obesity, a precursor to type 2 diabetes and cardiovascular disease, and might in part explain the association of depressive symptoms with adverse metabolic outcomes. We determined the cross-sectional association between depressive symptoms and body mass index (BMI) and waist circumference (WC) in 1,314 elderly men and women age 60 to 83 years in the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.

Relationship between the cortisol awakening response and other features of the diurnal cortisol rhythm: The Multi-Ethnic Study of Atherosclerosis.
By: Golden SH, Sanchez BN, Wu M, Champaneri S, Diez Roux AV, Seeman T, Wand GS.
Researchers for this study conclude that bedtime cortisol showed the strongest correlation with total cortisol area under the curve, suggesting it may be a marker of daily cortisol exposure.
Read on Pubmed
Methods for estimation of disparities in medication use in an observational cohort study: results from the Multi-Ethnic Study of Atherosclerosis.
By: McClelland RL, Jorgensen NW, Post WS, Szklo M, Kronmal RA.
Evaluating disparities in health care is an important aspect of understanding differences in disease risk. The purpose of this study is to describe the methodology for estimating such disparities, to provide improved disparity estimation in a large multi-ethnic cohort study.
Read on Pubmed
Patient- and trial-specific barriers to participation in cardiovascular randomized clinical trials.
By: Martin SS, Ou FS, Newby LK, Sutton V, Adams P, Felker GM, Wang TY.
This study quantitatively examined the association of patient- and trial-specific factors with participation in cardiovascular randomized clinical trials.
Read on Pubmed